by Anjaly Maria Jose | Nov 1, 2019 | Disease and Treatment
Disease management programs (DMPs) are defined as “structured treatment plans that aim to help people manage their chronic disease in a better way and to maintain as well as improve quality of life”. The main components of disease management programs are mentioned in...
by Anjaly Maria Jose | Oct 4, 2019 | Cancer
Breast cancer is a growing concern as it is reported to be the most common cancer in women worldwide. About 1.7 million new cases and 5,22,000 deaths from breast cancer occur every year. The number of deaths due to breast cancer (3,24,000) are high, in low and...
by Anjaly Maria Jose | Aug 30, 2019 | Publication Writing
Introduction A biosimilar product, as defined by USFDA, is “a biological product that is highly similar to and has no clinically meaningful differences from an existing FDA-approved reference product.” By 2020, the biosimilar market is expected to reach $15 billion...
by Anjaly Maria Jose | Mar 11, 2019 | Clinical Trials
In the clinical trials industry, 80% of trials do not meet enrolment timelines, leading to a loss of $8 million per day. Delayed enrolment not only impacts trial timelines, but more trials are being cancelled because of it, preventing investigators from...
by Anjaly Maria Jose | Sep 24, 2018 | Drugs and Disease
It is estimated that nearly 44 million people worldwide have Alzheimer’s or related dementia. The total number of people with Alzheimer’s is projected to almost double every 20 years. What really scares me is Alzheimer’s or premature senility, losing that...